Table 5.
Adjusted Odds of High Trust in Treatment Team According to Personal, Health Care, and Cancer-Related Factors (N = 704)
| Patient characteristics | Model 1 | Model 2† |
|---|---|---|
| OR (95% CI) | OR (95% CI) | |
| Trust in regular provider (Ref: not highest trust) | ||
| Highest trust | 3.09 (2.02–4.72)*** | 3.25 (2.06–5.14) |
| Trust in diagnosing doctor (Ref: not highest trust) | ||
| Highest trust | 4.47 (2.81–7.11)*** | 4.68 (2.82–7.77) |
| Race (ref: white) | ||
| Black | 0.45 (0.25–0.80)* | |
| Hispanic (English) | 0.61 (0.21–1.80) | |
| Hispanic (Spanish) | 2.12 (0.75–6.00) | |
| Insurance (ref: no insurance) | ||
| Public | 1.53 (0.61–3.84) | |
| Private | 0.89 (0.38–2.06) | |
| Number of recent exams (ref: 0 exams) | ||
| 1 | 0.43 (0.16–1.20) | |
| 2 | 0.74 (0.29–1.90) | |
| 3 | 0.57 (0.23–1.41) | |
| Number of comorbidities (ref: 0 comorbidities) | ||
| 1 | 1.58 (0.89–2.81) | |
| 2+ | 1.31 (0.66–2.59) | |
| Time with regular doctor (ref: <1 year) | ||
| 1–5 years | 1.14 (0.43–2.98) | |
| 6–10 years | 0.96 (0.36–2.55) | |
| >10 years | 0.74 (0.27–1.95) | |
| Cancer stage (ref: stage 0) | ||
| 1 | 0.89 (0.46–1.72) | |
| 2 | 0.54 (0.27–1.16) | |
| 3 | 0.42 (0.18–1.01) | |
| 4 | 0.27 (0.06–1.29) | |
| Days since diagnosis (ref: <85) | ||
| 85–108 | 0.78 (0.39–1.56) | |
| 109–148 | 0.60 (0.31–1.16) | |
| >149 | 0.59 (0.30–1.16) | |
| Chemotherapy (ref: no chemo) | ||
| Yes | 1.54 (0.87–2.72) | |
| Mastectomy (ref: no mastectomy) | ||
| Yes | 0.95 (0.59–1.53) | |
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
†The following variables are included in the model: age, marital status, income, education